What does DRS. ZEYEN-COSEMANS do?

DRS. ZEYEN-COSEMANS is a specialist medical practice in Schoten. Private Limited, started on 29 July 2004, 1 establishment.

What is the address of DRS. ZEYEN-COSEMANS?

The registered office of DRS. ZEYEN-COSEMANS is located at Alfons Servaislei 62, 2900 Schoten.

Is DRS. ZEYEN-COSEMANS still active?

Yes. According to the CBE (30 October 2026) DRS. ZEYEN-COSEMANS is active, legal situation “Normale toestand”, started on 29 July 2004.

Is DRS. ZEYEN-COSEMANS registered on Peppol?

Yes, DRS. ZEYEN-COSEMANS is registered on the Peppol network with ID 0208:0866599978.

What is the enterprise number of DRS. ZEYEN-COSEMANS?

The enterprise number of DRS. ZEYEN-COSEMANS is BE0866599978.

When was DRS. ZEYEN-COSEMANS founded?

DRS. ZEYEN-COSEMANS was founded on 29 July 2004.

Who are the directors of DRS. ZEYEN-COSEMANS?

According to the 2025 annual accounts, the directors of DRS. ZEYEN-COSEMANS are: Ine Cosemans, Philippe Zeyen.

Is DRS. ZEYEN-COSEMANS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 July 2004; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did DRS. ZEYEN-COSEMANS make in 2025?

DRS. ZEYEN-COSEMANS posted a profit after taxes of € 704,178 in financial year 2025.

What is the revenue of DRS. ZEYEN-COSEMANS?

As a small company, DRS. ZEYEN-COSEMANS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 1,352,819.

How much does an employee at DRS. ZEYEN-COSEMANS earn?

The average wage cost per full-time employee at DRS. ZEYEN-COSEMANS was € 74,400 in 2025: staff costs of € 148,738 for 2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does DRS. ZEYEN-COSEMANS have?

According to the 2025 annual accounts, DRS. ZEYEN-COSEMANS has 2 full-time equivalents (FTE).

DRS. ZEYEN-COSEMANS (Private Limited) - Schoten

Dossier DRS. ZEYEN-COSEMANS, printed on 30 October 2026 from databakkes.be/en/0866599978/drs-zeyen-cosemans. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DRS. ZEYEN-COSEMANS from Schoten, company number BE0866599978, closed financial year 2025 with a result of € 704,178 after tax. For that financial year DRS. ZEYEN-COSEMANS recorded a gross margin of € 1.4 million and equity of € 2.8 million. Compared with financial year 2024, the result moved from € 579,704 to € 704,178. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 9, 2026.

What it is worth Growing

€ 2.8 million

▲ 21% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 704,178

▲ 21% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 600,228

▲ 34% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 211,136 paid out

30 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

▲ 0.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 148,738

▲ 72% vs 2024

€ 74,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 266,684

▲ 70% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 491,352

▼ 20% vs 2024

€ 161,675 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 8,167

▼ 67% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 67,680

▲ 35% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 696,841 Gross margin 2022: € 696,841 First fiscal year in the series	€ 857,099 Gross margin 2023: € 857,099 ▲ 23% vs 2022 (€ 696,841) Favourable step	€ 1,098,254 Gross margin 2024: € 1,098,254 ▲ 28% vs 2023 (€ 857,099) Favourable step	€ 1,352,819 Gross margin 2025: € 1,352,819 ▲ 23% vs 2024 (€ 1,098,254) Favourable step	▲ 23%
Profit after taxes	€ 315,448 Profit after taxes 2022: € 315,448 First fiscal year in the series	€ 395,829 Profit after taxes 2023: € 395,829 ▲ 25% vs 2022 (€ 315,448) Favourable step	€ 579,704 Profit after taxes 2024: € 579,704 ▲ 46% vs 2023 (€ 395,829) Favourable step	€ 704,178 Profit after taxes 2025: € 704,178 ▲ 21% vs 2024 (€ 579,704) Favourable step	▲ 21%
Equity	€ 1,761,508 Equity 2022: € 1,761,508 First fiscal year in the series	€ 1,971,075 Equity 2023: € 1,971,075 ▲ 12% vs 2022 (€ 1,761,508) Favourable step	€ 2,336,658 Equity 2024: € 2,336,658 ▲ 19% vs 2023 (€ 1,971,075) Favourable step	€ 2,829,701 Equity 2025: € 2,829,701 ▲ 21% vs 2024 (€ 2,336,658) Favourable step	▲ 21%
Total debts	€ 915,579 Total debts 2022: € 915,579 First fiscal year in the series	€ 862,876 Total debts 2023: € 862,876 ▼ 6% vs 2022 (€ 915,579) Favourable step	€ 749,189 Total debts 2024: € 749,189 ▼ 13% vs 2023 (€ 862,876) Favourable step	€ 608,883 Total debts 2025: € 608,883 ▼ 19% vs 2024 (€ 749,189) Favourable step	▼ 19%
Cash	€ 198,674 Cash 2022: € 198,674 First fiscal year in the series	€ 109,297 Cash 2023: € 109,297 ▼ 45% vs 2022 (€ 198,674) Unfavourable step	€ 449,581 Cash 2024: € 449,581 ▲ € 340,284 vs 2023 (€ 109,297) Favourable step	€ 600,228 Cash 2025: € 600,228 ▲ 34% vs 2024 (€ 449,581) Favourable step	▲ 34%
Land & buildings	€ 1,737,181 Land & buildings 2022: € 1,737,181 First fiscal year in the series	€ 1,692,775 Land & buildings 2023: € 1,692,775 ▼ 3% vs 2022 (€ 1,737,181) Unchanged	€ 1,648,370 Land & buildings 2024: € 1,648,370 ▼ 3% vs 2023 (€ 1,692,775) Unchanged	€ 1,606,173 Land & buildings 2025: € 1,606,173 ▼ 3% vs 2024 (€ 1,648,370) Unchanged	▼ 3%
Retained profit	€ 1,742,908 Retained profit 2022: € 1,742,908 First fiscal year in the series	€ 1,952,475 Retained profit 2023: € 1,952,475 ▲ 12% vs 2022 (€ 1,742,908) Favourable step	€ 2,318,058 Retained profit 2024: € 2,318,058 ▲ 19% vs 2023 (€ 1,952,475) Favourable step	€ 2,811,101 Retained profit 2025: € 2,811,101 ▲ 21% vs 2024 (€ 2,318,058) Favourable step	▲ 21%
Dividend	€ 132,526 Dividend 2022: € 132,526 First fiscal year in the series	€ 186,262 Dividend 2023: € 186,262 ▲ 41% vs 2022 (€ 132,526) Unchanged	€ 214,122 Dividend 2024: € 214,122 ▲ 15% vs 2023 (€ 186,262) Unchanged	€ 211,136 Dividend 2025: € 211,136 ▼ 1% vs 2024 (€ 214,122) Unchanged	▼ 1%
Bank debt	€ 873,192 Bank debt 2022: € 873,192 First fiscal year in the series	€ 776,810 Bank debt 2023: € 776,810 ▼ 11% vs 2022 (€ 873,192) Favourable step	€ 615,813 Bank debt 2024: € 615,813 ▼ 21% vs 2023 (€ 776,810) Favourable step	€ 491,352 Bank debt 2025: € 491,352 ▼ 20% vs 2024 (€ 615,813) Favourable step	▼ 20%
Balance sheet total	€ 2,677,087 Balance sheet total 2022: € 2,677,087 First fiscal year in the series	€ 2,833,951 Balance sheet total 2023: € 2,833,951 ▲ 6% vs 2022 (€ 2,677,087) Unchanged	€ 3,085,847 Balance sheet total 2024: € 3,085,847 ▲ 9% vs 2023 (€ 2,833,951) Unchanged	€ 3,438,583 Balance sheet total 2025: € 3,438,583 ▲ 11% vs 2024 (€ 3,085,847) Unchanged	▲ 11%
Employees (FTE)	1.6 Employees (FTE) 2022: 1.6 First fiscal year in the series	1.6 Employees (FTE) 2023: 1.6 Unchanged (1.6) Unchanged	1.9 Employees (FTE) 2024: 1.9 ▲ 0.3 vs 2023 (1.6) Unchanged	2 Employees (FTE) 2025: 2 ▲ 0.1 vs 2024 (1.9) Unchanged	▲ 0.1

Key figures of DRS. ZEYEN-COSEMANS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DRS. ZEYEN-COSEMANS?

What happened at DRS. ZEYEN-COSEMANS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 9, 2026 New annual accounts for financial year 2025: profit of € 704,178 (▲ 21% vs 2024). Source: NBB ↗
Jul 29, 2004 New establishment in Schoten. KBO
Jul 29, 2004 Start of the company according to the CBE. KBO

In short

From € 315,448 profit in 2022 to € 704,178 profit in 2025.

Paid € 909,968 in corporate taxes since 2022.

Best year ever: 2025, with € 704,178 profit.

On average € 676,400 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Ine Cosemans 50%

Philippe Zeyen 50%

DRS. ZEYEN-COSEMANS

L.V.C. 2.7%

Behind DRS. ZEYEN-COSEMANS are Ine Cosemans and Philippe Zeyen. The shares are held by Ine Cosemans (50%) and Philippe Zeyen (50%). It owns 2.7% of L.V.C. itself.

Directors

According to the 2025 annual accounts

Ine Cosemans

Director

Owns 50% directly

Philippe Zeyen

Director

Owns 50% directly

Shareholders

Ine Cosemans · director

50%

Philippe Zeyen · director

50%

Participations

L.V.C.

2.7%

Establishments

Establishment units

Physical locations of this company

Registered office

Alfons Servaislei 62

2900 Schoten

2.229.711.086

Taxanderlei 13

2900 Schoten

Active since 29 July 2004

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0866.599.978

VAT number

BE 0866.599.978

Registered office

Alfons Servaislei 62, 2900 Schoten

Names & denominations

DRS. ZEYEN-COSEMANS

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

29 July 2004

Peppol

Active · Active since 13 May 2025

Activities · NACE

Activiteiten van medisch specialisten

Medische praktijken

View on CBE Public ↗ Annual accounts (NBB) ↗

DRS. ZEYEN-COSEMANS

Financials

What happened to DRS. ZEYEN-COSEMANS?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions